• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key.

作者信息

Payne Katherine

出版信息

Pharmacogenomics. 2008 Jan;9(1):1-4. doi: 10.2217/14622416.9.1.1.

DOI:10.2217/14622416.9.1.1
PMID:18154442
Abstract
摘要

相似文献

1
Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key.
Pharmacogenomics. 2008 Jan;9(1):1-4. doi: 10.2217/14622416.9.1.1.
2
On pharmacogenomics and cost-effectiveness analysis at the individual level.
Pharmacoeconomics. 2005;23(5):527. doi: 10.2165/00019053-200523050-00011.
3
Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?
Pharmacoeconomics. 2005;23(5):445-7. doi: 10.2165/00019053-200523050-00004.
4
Practical considerations for pharmacogenetic testing.药物遗传学检测的实际考量
MLO Med Lab Obs. 2001 Sep;33(9):16-21, 23; quiz 24-5.
5
Making decisions on technology availability in the British National Health Service--why we need reliable models.关于英国国家医疗服务体系中技术可用性的决策——为何我们需要可靠的模型。
Value Health. 2003 Jan-Feb;6(1):3-5. doi: 10.1046/j.1524-4733.2003.00002.x.
6
How much are health-care systems prepared to pay to produce a QALY?
Eur J Health Econ. 2005 Dec;6(4):285-7. doi: 10.1007/s10198-005-0325-y.
7
Occupational therapy compared with social work assessment for older people. An economic evaluation alongside the CAMELOT randomised controlled trial.针对老年人的职业疗法与社会工作评估的比较：一项与CAMELOT随机对照试验同步进行的经济评估。
Age Ageing. 2005 Jan;34(1):47-52. doi: 10.1093/ageing/afh232. Epub 2004 Nov 10.
8
Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.临床实践中药物基因组学的成本效益：欧洲急性淋巴细胞白血病中硫嘌呤甲基转移酶基因分型的案例研究
Pharmacogenomics. 2006 Jul;7(5):783-92. doi: 10.2217/14622416.7.5.783.
9
Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.审视成本效益分析的美好一面：对英国国家卫生与临床优化研究所（NICE）技术评估中成本效益分析使用情况的定性调查
Health Econ. 2007 Feb;16(2):179-93. doi: 10.1002/hec.1133.
10
Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.实用药物遗传学：对接受硫唑嘌呤治疗的风湿病患者进行硫嘌呤甲基转移酶基因多态性筛查的成本效益分析
J Rheumatol. 2002 Dec;29(12):2507-12.

引用本文的文献

1
Issues surrounding the health economic evaluation of genomic technologies.基因组技术健康经济评估相关问题。
Pharmacogenomics. 2013 Nov;14(15):1833-47. doi: 10.2217/pgs.13.183.
2
Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain.改善欧洲的药物警戒：英国和西班牙的硫嘌呤甲基转移酶基因分型与表型分析
Eur J Hum Genet. 2009 Aug;17(8):991-8. doi: 10.1038/ejhg.2009.10. Epub 2009 Feb 18.